Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Powershares S&P Smallcap Low Vo | XSLV | Sep 30, 2024 | 48.12 | +0.40 |
PowerShares Variable Rate Investment Grade Portfolio | VRIG | Sep 30, 2024 | 25.09 | -0.02 |
PowerUp Acquisition A | PWUP | Sep 30, 2024 | 12.21 | +5.35 |
PowerUp Acquisition Unit | PWUPU | Sep 30, 2024 | 12.78 | +7.12 |
PPG Industries | PPG | Sep 30, 2024 | 132.46 | -1.56 |
PPL | PPL | Sep 30, 2024 | 33.08 | +0.61 |
PRA Group | PRAA | Sep 30, 2024 | 22.36 | -1.28 |
Prairie Operating | PROP | Sep 30, 2024 | 8.76 | 0.00 |
Praxis Precision Medicines | PRAX | Sep 30, 2024 | 57.54 | -0.50 |
Precigen | PGEN | Sep 30, 2024 | 0.95 | +0.06 |
Precipio | PRPO | Sep 30, 2024 | 6.70 | +2.13 |
Precision BioSciences | DTIL | Sep 30, 2024 | 8.96 | -0.99 |
Precision Drilling | PDS | Sep 30, 2024 | 61.65 | -0.42 |
Precision Optics | POCI | Sep 30, 2024 | 5.58 | -2.79 |
Predictive Oncology | POAI | Sep 30, 2024 | 0.79 | +0.25 |
Preferred Bank | PFBC | Sep 30, 2024 | 80.25 | +0.77 |
Preferred Portfolio Powershares | PGX | Sep 30, 2024 | 12.35 | -0.72 |
Preformed Line Products | PLPC | Sep 30, 2024 | 128.08 | -1.89 |
Prelude Therapeutics | PRLD | Sep 30, 2024 | 2.07 | -2.36 |
Premier A | PINC | Sep 30, 2024 | 20.00 | +0.05 |
Premier Financial | PFC | Sep 30, 2024 | 23.48 | +1.51 |
Prenetics Global A | PRE | Sep 30, 2024 | 4.00 | -2.79 |
Presidio Property Trust A | SQFT | Sep 30, 2024 | 0.72 | +3.16 |
Presidio Property Trust D Pref | SQFTP | Sep 30, 2024 | 15.40 | -0.32 |
Prestige Consumer Healthcare | PBH | Sep 30, 2024 | 72.10 | +1.09 |
Prestige Wealth | PWM | Sep 30, 2024 | 0.83 | +3.11 |
PriceSmart | PSMT | Sep 30, 2024 | 91.78 | +0.51 |
Prime Medicine | PRME | Sep 30, 2024 | 3.87 | +11.85 |
Primech Holdings | PMEC | Sep 30, 2024 | 0.79 | +0.04 |
PrimeEnergy Resources | PNRG | Sep 30, 2024 | 137.80 | -1.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.